Gastrointestinal symptoms such as nausea or mild stomach discomfort were also reported during early treatment or following dose escalation
Weight Loss Results with Tirzepatide Clinical trials have shown that tirzepatide can lead to average weight loss of 15 to 22 percent or more of total body weight
For example, a 3 mL dose becomes two 1.5 mL injections in opposite abdominal quadrants
Additionally, GlyNAC supplementation resulted in the upregulation of mitophagy and Pax7 expression, as well as downregulation of 8-OHdG, p16INK4, and Muscle POT1 expression, respectively indicating the impacts on loss of proteostasis, stem-cell exhaustion, genomic damage, cellular senescence, and telomere attrition
Usually, a 27 to 30 G needle that's around 1/2" long will suffice